Not applicableLooking for participantsNCT06344416
What this trial is testing
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Who this might be right for
Any Solid Oral Medication
Dosentrx Ltd. 200